|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/52 | |||
| A61K 31/522 | |||
| A61P 1/00 | |||
| A61P 3/10 | |||
| A61P 9/00 | |||
| A61P 11/06 | |||
| A61P 15/00 | |||
| A61P 17/06 | |||
| A61P 17/00 | |||
| A61P 19/02 | |||
| A61P 25/28 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| A61P 37/06 | |||
| C07D 487/04 |
| (11) | Number of the document | 2029145 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07811927.8 |
| Date of filing the European patent application | 2007-05-24 | |
| (97) | Date of publication of the European application | 2009-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/069595 |
| Date | 2007-05-24 |
| (87) | Number | WO 2007/140222 |
| Date | 2007-12-06 |
| (30) | Number | Date | Country code |
| 808605 P | 2006-05-26 | US |
| (72) |
BRAIN, Christopher Thomas, US
THOMA, Gebhard, DE
SUNG, Moo Je, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Astex Therapeutics Limited, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, GB |
| (54) | PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES |
| PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES |